Cannabis Rescheduling: Page 4

Trump Is In: Will Pro-Cannabis Reform Be In or Out?

What will the new administration and a Republican-controlled Congress mean for cannabis policy? Could we see movement on SAFER Banking before the transition? National Cannabis Roundtable Policy Director David Mangone shares his insights.

Cannabis Rescheduling Judge Authorizes Prohibitionist Group to Respond to Collusion Claims

Smart Approaches to Marijuana was accused of working behind the scenes with the DEA before an administrative law judge hearing was granted.

Cannabis Rescheduling Advocates Say DEA Stacked Deck, Colluded With Prohibitionists

An administrative law judge is giving the DEA five days to respond to the allegations—if it wants to—after he already approved the hearing’s participant list.

Is Trump Good for Cannabis? MariMed CEO Explains

Jon Levine, who also serves as the company’s president, goes into detail about a heads-down business approach that supersedes White House politics.

Trump’s Pick for Attorney General Promising for Cannabis Policy, Rescheduling

Matt Gaetz has long supported cannabis reform during his time in the U.S. House, including his position that cannabis should be decontrolled.

DEA Names 25 Participants for Cannabis Rescheduling Hearing That’s Now Delayed Until 2025

An administrative law judge issued an order pushing back testimonies until January or February.

Kamala Harris Adds ‘Legalize Recreational Marijuana’ to To-Do List

The Democratic presidential candidate included cannabis reform among 14 items on her immediate priority list.

Cannabis Rescheduling Won’t Solve Industry Banking Problems, Legal Risks

Bank Secrecy Act obligations and federal anti-money laundering laws would still apply to cannabis under a Schedule III listing, legal expert says.

Kamala Harris Vows to Legalize Cannabis as ‘Law of the Land,” Fight for National Industry

The presidential candidate said she plans to legalize marijuana at the federal level to break down ‘unjust legal barriers’ for Black men and other Americans.

2 US House Democrats Nudge DEA to ‘Swiftly’ Reschedule Cannabis

Reps. Jerry Nadler and Frank Pallone Jr., both ranking members, wrote a letter to the attorney general and DEA administrator.

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

Previous Page

Page 4 of 12

Next Page